As lawsuit carries on against Guardant Health, CFO shakeup hits Illumina; Pfizer-backed biotech taps CEO to lead pursuit of gene therapy 2.0
→ Sam Samad is out as CFO of Illumina as chief strategy and corporate development officer Joydeep Goswami slides in for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
